Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $23,476,855 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 150 grants at over 100 hospitals in 29 countries.
Duke University Hospital – $50,000
$50,000.00
September 2021
Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors
Funding of PBTCF 2021: PBTC-059 - $25,000
$25,000.00
January 2021
Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma
International DIPG/DMG Registry And Repository - $1,508,198
$1,508,198.00
December 2020
Children's Cancer Institute - $99,251
$99,251.00
September 2020
Discovering New Epigenetic Players in DIPG Oncogenesis
Northwestern Memorial Hospital - $110,000
$110,000.00
September 2020
Development of Histone Demethylase Inhibitor Against DIPG
The Hospital for Sick Children - $100,000
$100,000.00
September 2020
Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma
Hunter Medical Research Institute - $145,640
$145,640.00
September 2020
Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas
CONNECT Consortium - $489,801.26
$489,801.00
September 2020
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium
International DIPG/DMG Registry And Repository - $862,671
$862,671.00
May 2020
Funding of PBTCF 2020: PBTC-058 - $25,000
$25,000.00
January 2020
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma
Sydney Children's Hospital - $151,468
$151,468.00
December 2019
Developing New Epigenetic Combination Treatments Against DIPG.
Oncoceutics ONC201 - $100,000
$100,000.00
December 2019
Expansion of the ONC201 Compassionate Use.
University of Sydney - $100,000
$100,000.00
November 2019
Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.
University of Michigan Hospitals - $157,856
$157,856.00
November 2019
Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG
Dayton Children's Hospital - $69,600
$69,600.00
November 2019
Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.